Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company focused on developing innovative cell and antibody therapies for cancer and viral infections. Its core activities include advancing natural killer (NK) cell platforms, CAR T-cell technologies, and diagnostic tools. The company collaborates with academic and industry partners to develop targeted treatments, aiming to improve efficacy and safety in oncology and infectious disease markets.
This description was generated via AI from an annual report. Updated about 1 year ago.